Cosmo Pharmaceuticals N.V.

Direct answer

Cosmo Pharmaceuticals N.V. is publicly traded on SIX under the ticker COPN.SW.

Cosmo Pharmaceuticals N.V. operates as a specialized biopharmaceutical firm, primarily focused on the global development and commercialization of treatments and diagnostic tools within the gastroenterology and endoscopy fields. Its product lineup includes oral tablet formulations like Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, which are prescribed to achieve remission in cases of active, mild to moderate...

Can you invest in Cosmo Pharmaceuticals N.V.?

Yes. Cosmo Pharmaceuticals N.V. trades publicly on SIX as COPN.SW.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Cosmo Pharmaceuticals N.V.

Detailed equity research is provided by MarketSnap.